TransDigm Group, Inc. (TDG)

1116.20 +10.92 (+0.99%) USD  |  NYSE  |  Sep 25, 16:00
1116.23 +0.03 (+0.00%) After-Hours: 19:59
More

TransDigm Group R&D to Revenue (TTM)

R&D to Revenue (TTM) Chart

View R&D to Revenue (TTM) for TDG.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View R&D to Revenue (TTM) Chart
Start Trial

Historical R&D to Revenue (TTM) Data

View and export this data back to 2015. Start Trial.
Date Value
September 30, 2015 --

R&D to Revenue Definition

The Research & Development (R&D) Expense to Revenue ratio measures the percentage of sales that is allocated to R&D expenditures. It is not as effective when looking at companies in different industries because different industries place different values on R&D. Technology companies and pharmaceutical companies are more likely to have high R&D ratios.

Read full definition.

R&D to Revenue (TTM) Range, Past 5 Years

View R&D to Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

R&D to Revenue (TTM) Benchmarks

View R&D to Revenue (TTM) Benchmarks
Start Trial
Woodward, Inc. Upgrade
The Boeing Co. Upgrade
Howmet Aerospace, Inc. Upgrade
RTX Corp. Upgrade
GE Aerospace Upgrade